Summary
Cardinal Health, Inc. (CAH) has filed an 8-K reporting the results of its 2025 Annual Meeting of Shareholders, held on November 5, 2025. The meeting primarily focused on shareholder votes concerning the Board of Directors, executive compensation, and the ratification of the independent auditor. All 12 director nominees were overwhelmingly elected, indicating strong shareholder confidence in the current board's leadership and strategic direction. The company also received a positive advisory vote on executive compensation, reflecting shareholder approval of the compensation packages for its named executive officers. Furthermore, shareholders ratified the appointment of Ernst & Young LLP as the independent auditor for the upcoming fiscal year. This outcome suggests a stable governance environment and continued support for the company's financial oversight. Investors should view these results as indicators of continued operational and strategic stability within Cardinal Health.
Key Highlights
- 1All 12 director nominees were elected to the Board of Directors with significant 'For' votes, indicating strong shareholder confidence.
- 2The advisory vote on executive compensation ('say-on-pay') was approved, with a substantial majority of shareholders voting in favor.
- 3Ernst & Young LLP was ratified as the independent auditor for the fiscal year ending June 30, 2026, with overwhelming shareholder approval.
- 4The director election results show high levels of support, with most nominees receiving over 185 million 'For' votes.
- 5Broker non-votes were present for the director and executive compensation proposals, but not for the auditor ratification, indicating a majority of shares represented were in favor of the auditor.
- 6The outcomes suggest shareholder alignment with the company's current governance and financial reporting practices.